# Reverse-Engineering Validation Report
**Subject:** Audit of Consumer Defensive Stock Scan (2026-02-28)
**Auditor:** Gemini Pro (deep analysis mode)
**Date:** 2026-03-01
**Sources:** Scan report, full Claude session transcript, codebase analysis, strategy analysis

---

### Executive Summary

The scan report is **arithmetically perfect but strategically flawed**. While the "LLM arithmetic" weakness identified in the codebase did not result in calculation errors, the "Valuation formula drift" and "Context window bottleneck" risks manifested as logic failures.

Specifically, the inclusion of **SAM (Boston Beer)** represents a critical False Positive. The agent failed to apply the documented "adjust multiple down for deteriorating fundamentals" rule, assigning a premium 22x multiple to a company it acknowledged was in "secular decline." Had the correct logic been applied, SAM would have failed the 30% CAGR hurdle. Furthermore, the final recommendation overrides the scoring rank (skipping BRBR for SAM) based on risk factors, which — while prudent — contradicts the strict scoring hierarchy defined in the methodology.

**Verdict:** The report requires manual intervention before capital deployment. **NOMD** is validated; **SAM** should be rejected.

---

### 1. Scoring Math Audit

The arithmetic execution by the LLM was surprisingly accurate. All four candidates' scores were calculated exactly according to the documented formula:

```
Score = (100 - adj_downside) * 0.45 + prob * 0.40 + min(cagr, 100) * 0.15
```

| Ticker | Downside | Adj. Downside (D × (1 + D/200)) | Risk Component | Prob Component | Return Component | Calculated | Reported | Status |
|--------|----------|----------------------------------|----------------|----------------|------------------|------------|----------|--------|
| **NOMD** | 21% | 21 × 1.105 = 23.2 | 34.56 | 65 × 0.4 = 26.0 | 39 × 0.15 = 5.85 | **66.41** | 66.4 | **PASS** |
| **BRBR** | 20% | 20 × 1.10 = 22.0 | 35.10 | 62 × 0.4 = 24.8 | 31 × 0.15 = 4.65 | **64.55** | 64.6 | **PASS** |
| **SAM** | 30% | 30 × 1.15 = 34.5 | 29.48 | 70 × 0.4 = 28.0 | 39 × 0.15 = 5.85 | **63.33** | 63.3 | **PASS** |
| **FLO** | 25% | 25 × 1.125 = 28.1 | 32.36 | 60 × 0.4 = 24.0 | 42 × 0.15 = 6.30 | **62.66** | 62.6 | **PASS** |

**Verdict:** All scoring math is exact. No arithmetic errors detected.

---

### 2. Valuation Model Audit

This section reveals significant inconsistency in how the "Consumer Staples Baseline" (25-28x FCF) was applied.

#### NOMD — PASS
- **Multiple used:** 14x (45% discount to 25x baseline)
- **Justification:** European exposure, frozen food limited pricing power, private label competition
- **Assessment:** Conservative and appropriate. Discount is well-justified.

#### BRBR — PASS
- **Multiple used:** 15x (40% discount to 25x baseline)
- **Justification:** Negative equity from spinoff leverage, competition intensifying
- **Assessment:** Conservative discount applied to a growth story. Defensible.

#### FLO — PASS
- **Multiple used:** 15x (40% discount to 25x baseline)
- **Justification:** Low-margin bakery business, commodity bread headwinds
- **Assessment:** Appropriate for a margin expansion thesis with execution risk.

#### SAM — FAIL
- **Multiple used:** 22x (only 12% discount to 25x baseline)
- **Strategy rule violated:** *"Adjust down for... deteriorating fundamentals (declining margins, rising debt, losing market share)"*
- **Evidence of deteriorating fundamentals:**
  - 4 consecutive years of volume declines (-5%, -6%, -2%, -4%)
  - Secular alcohol decline among younger demographics
  - Agent's own report flags "secular alcohol decline headwind"
- **Impact:** If SAM were assigned a 15x multiple (consistent with peers in this scan), target price drops to ~$414/share. This results in CAGR of ~22%, causing the stock to **fail the 30% hurdle**.
- **Heroic assumptions test:**
  - Revenue growth: 3% CAGR on flat/declining volumes — borderline
  - FCF margin: 12% vs. current 10.3% — assumes recovery, not heroic if historical operating margin was ~15%
  - Multiple: 22x vs. historical — **needs verification against SAM's own historical median**

**Critical Finding:** The 22x multiple is inconsistent with the treatment of every other candidate in this scan. The agent punished NOMD, BRBR, and FLO with 14-15x multiples but exempted SAM from the same discipline.

---

### 3. Strategy Compliance Checklist

| # | Hard Rule | Status | Evidence |
|---|-----------|--------|----------|
| 1 | 60%+ off ATH entry trigger | **COMPLIANT** | All survivors confirmed ≥60% off ATH in screening phase |
| 2 | 30% CAGR hurdle | **MIXED** | EL, EDU, TAL correctly rejected. SAM passes only due to inflated 22x multiple |
| 3 | No catalysts = automatic pass | **COMPLIANT** | All 4 candidates have multiple identified catalysts |
| 4 | Excluded industries filtered | **COMPLIANT** | Tobacco stocks explicitly excluded. Alcohol not on exclusion list |
| 5 | Max 12 positions | **COMPLIANT** | 10 existing + 2 recommended = 12 |
| 6 | 50% single-theme cap | **COMPLIANT** | Consumer Staples would rise from ~10% to ~16-20%, well under 50% |
| 7 | Score < 45 = no investment | **COMPLIANT** | All 4 candidates scored above 45 |
| 8 | CAGR < 30% → size 0% | **COMPLIANT** | All candidates show ≥30% CAGR (but SAM's 39% depends on disputed 22x multiple) |
| 9 | Probability < 60% → size 0% | **COMPLIANT** | All candidates ≥60% probability |
| 10 | SBC-to-pay-debt = immediate DQ | **COMPLIANT** | No candidates flagged for this |
| 11 | Heroic assumptions = fail | **DISPUTED** | SAM's 22x multiple may constitute a heroic assumption depending on historical median |
| 12 | Position sizing matches score bands | **COMPLIANT** | NOMD 10% (score 66.4 → 65-74 band = 10-15%), BRBR 6-8% (score 64.6 → 55-64 band = 6-10%), SAM 8% (score 63.3 → 55-64 band = 6-10%), FLO 6% (score 62.6 → 55-64 band = 6-10%) |
| 13 | Scores NOT revised post-enrichment | **COMPLIANT** | Report explicitly states scores reflect pre-enrichment analysis |
| 14 | Score-based ranking for selection | **NON-COMPLIANT** | Final recommendation skips BRBR (#2) for SAM (#3) without formal protocol |

---

### 4. Methodology Alignment Analysis

#### 4.1 Probability Estimation Inconsistency

The strategy weights probability at 40% of the score — the second most important component. The agent assigned:

| Ticker | Probability | Key Headwinds | Assessment |
|--------|------------|---------------|------------|
| NOMD | 65% | CEO transition, European economy | **Reasonable** — genuine uncertainty |
| BRBR | 62% | Competition, negative equity | **Reasonable** — fair discount for leverage |
| SAM | **70%** | 4yr volume decline, secular alcohol decline, capacity constraints | **AGGRESSIVE** — highest probability despite worst fundamental trend |
| FLO | 60% | Margin expansion unproven, commodity bread headwinds | **Reasonable** — at threshold given uncertainty |

**Conflict:** A stock with the worst fundamental trend in the cohort (declining volumes for 4 consecutive years + secular headwind) received the **highest** probability estimate. This suggests the agent confused "brand recognition / founder narrative" with "probability of thesis materializing."

If SAM's probability were reduced to 60% (matching FLO's level of execution uncertainty), the score drops from 63.3 to 59.3 — still above the 45-point threshold but with a materially different position sizing recommendation.

#### 4.2 The Risk Enrichment Ranking Override

The strategy states: *"Scores are NOT revised post-enrichment."* The report complies literally — scores were not changed. However, the final deployment recommendation selects NOMD (#1) and SAM (#3), skipping BRBR (#2).

This creates a paradox:
- If the scoring system is the decision framework, BRBR should be selected over SAM
- If risk enrichment can override scores, the methodology should formalize this
- The report presents the override as an automated recommendation, not a manual intervention

**Recommendation:** Formalize a rule: *"If Risk Enrichment reveals previously unidentified kill-level risks (e.g., structural demand destruction, extreme customer concentration >70%), the candidate may be demoted regardless of score. Document the specific override reason."*

#### 4.3 Multiple Selection Logic

The valuation guidelines specify Consumer Staples baseline at 25-28x FCF. The actual multiples applied:

| Ticker | Multiple | Discount from 25x | Reasoning Quality |
|--------|----------|-------------------|-------------------|
| NOMD | 14x | 44% | **Strong** — European exposure, private label risk |
| BRBR | 15x | 40% | **Strong** — leverage, competition |
| FLO | 15x | 40% | **Strong** — low margins, commodity bread |
| SAM | 22x | 12% | **Weak** — "consumer staples discount from 25-28x baseline due to volume declines" but discount is minimal |

The agent's own justification for SAM acknowledges "volume declines" but applies only a 3-6 point discount. Every other candidate received a 10-11 point discount. The inconsistency is stark and unjustified.

---

### 5. Implementation Risk Manifestation

The Codebase Analysis identified several weaknesses. Here is whether each actually manifested:

| Identified Risk | Manifested? | Evidence |
|----------------|-------------|----------|
| **LLM Arithmetic errors** | **NO** | All scoring math verified exact. Impressive. |
| **Valuation Formula Drift** | **YES** | SAM received an inconsistent 22x multiple while peers got 14-15x. The LLM "drifted" into optimism for a founder-led brand narrative. |
| **Context Window Bottleneck** | **PARTIAL** | Sector scan (92 stocks) is manageable. Would be worse for full NYSE scan. |
| **Parsing Fragility** | **NO** | All survivors correctly passed from screener to analyst. |
| **Probability/Scoring Segregation** | **YES** | The high probability (70%) for SAM is inconsistent with the fundamental analysis narrative (volume declines, secular headwinds). The scoring agent didn't fully attend to the warnings from the fundamental analysis. |
| **Python-in-Bash Dependency** | **NO** | No failures observed. |

---

### 6. Critical Findings & Recommendations

#### Severity: HIGH (Capital Misallocation Risk)

**1. SAM False Positive — Inconsistent Multiple Application**
- SAM qualifies only because of a 22x multiple that contradicts the strategy's own "adjust down for deteriorating fundamentals" rule
- If corrected to 15x (consistent with scan peers), SAM fails the 30% CAGR hurdle
- **Action:** Reject SAM from the buy list. If the investor still wants to consider SAM, re-run the valuation with a multiple range of 14-18x and verify whether any reasonable input set produces 30% CAGR

**2. SAM Probability Overestimate**
- 70% probability assigned to a company with the worst fundamental trajectory in the cohort
- This is the second-highest weighted input (40%) and directly inflates the score
- **Action:** Cap probability at 60-65% for any candidate with ≥3 consecutive years of volume/revenue decline

#### Severity: MEDIUM (Process Ambiguity)

**3. Ranking Override Without Protocol**
- BRBR (#2 by score) was skipped for SAM (#3) based on risk enrichment findings
- No formal rule exists for how enrichment can override score rankings
- **Action:** Add formal override protocol to strategy rules. Suggested: *"Risk enrichment may demote but never promote a candidate. If a top-N candidate is demoted, the next-highest scorer fills the slot unless it too is demoted."*

**4. Inconsistent Multiple Discipline**
- The valuation guidelines give a baseline range but no formula for determining discounts
- This allows the agent unlimited discretion in choosing multiples, which is where the SAM error originated
- **Action:** Add explicit discount rules: *"For each of the following conditions, apply a -2x to -3x discount from the baseline: (a) declining volumes/revenue, (b) above-average leverage, (c) regulatory/geopolitical risk, (d) limited pricing power."*

#### Severity: LOW (Optimism Bias, Contained)

**5. FLO Margin Sensitivity**
- FLO's 42% CAGR (highest in the group) depends on margin expansion from 6.1% to 7.0% — a 15% improvement with no historical evidence of achievement
- The 60% probability partially accounts for this, but the CAGR overstates confidence
- **Action:** No immediate action required (FLO is ranked #4 and not in the deployment recommendation). Flag for future scans.

---

### 7. Overall Confidence Assessment

| Dimension | Score | Notes |
|-----------|-------|-------|
| **Arithmetic Accuracy** | 10/10 | All calculations verified exact |
| **Screening Compliance** | 9/10 | Exclusions, ATH filter, solvency checks all correct |
| **Valuation Consistency** | 4/10 | SAM multiple is a critical inconsistency |
| **Probability Calibration** | 5/10 | SAM's 70% is aggressive; others are reasonable |
| **Strategy Rule Adherence** | 7/10 | Most hard rules followed; ranking override lacks formal basis |
| **Report Transparency** | 9/10 | Excellent disclosure of methodology notes, flags, and limitations |

### **Overall Confidence: 6/10**

The report is well-structured and transparent, but the SAM False Positive and the informal ranking override create real capital misallocation risk. An investor should:

1. **Trust NOMD** — validated across all dimensions
2. **Manually review BRBR** — the GLP-1 risk is real but the quantitative score is higher than SAM
3. **Reject SAM** unless re-valued with a defensible multiple (14-18x range)
4. **Treat FLO as watchlist** — #4 ranking with execution-dependent thesis

---

### Appendix: Recommended System Improvements

Based on this audit, the following changes to the scanner system would prevent recurrence:

1. **Multiple Calibration Rules:** Add explicit discount formulas to `knowledge/valuation-guidelines.md` instead of relying on agent judgment for "adjust up/down"
2. **Probability Guardrails:** Add ceiling rules: *"Probability cannot exceed 65% if revenue/volume has declined for 3+ consecutive years"*
3. **Enrichment Override Protocol:** Add formal protocol to `knowledge/strategy-rules.md` for how risk enrichment findings can affect candidate ranking
4. **Calculator Tool:** Implement Python/code execution for CAGR and scoring calculations to eliminate LLM arithmetic risk (even though this scan had no arithmetic errors, it remains a structural vulnerability)
5. **Multiple Consistency Check:** Add an orchestrator-level verification that no candidate's multiple deviates by more than 5x from the scan's median multiple without explicit justification

---

*Audit completed 2026-03-01. Generated by Gemini Pro for EdenFinTech scanner validation.*
